Clinical Trial Update: Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

View source ↗

Summary

Completed clinical study evaluating dried blood spot sampling to measure everolimus exposure in cancer patients (SPOT-study), led by Radboud University Medical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Breast Cancer, Renal Cell Carcinoma | Status: COMPLETED